Mainz Biomed BV Strategic Asset Allocation Index
Mainz Biomed BV strategic asset allocation index. Mainz Biomed BV (MYNZ) has a Strategic Asset Allocation Index of 3.4% as of June 2022. Strategic assets (PP&E of $805.51K plus long-term investments of $-) total $805.51K, measured against net assets of $23.77 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See MYNZ equity to assets ratio to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Strategic Asset Allocation Index of Mainz Biomed BV (2021–2021)
Strategic asset allocation index of Mainz Biomed BV from 2021 to 2021. This chart shows how Mainz Biomed BV's Strategic Asset Allocation Index has evolved across 1 annual periods from 2021 to 2021. As of June 2022, the index stands at 3.4%, representing strategic assets of $805.51K against net assets of $23.77 Million USD. Check tangible net worth ratio of Mainz Biomed BV to evaluate the tangible quality of the company's equity base.
Mainz Biomed BV Strategic Asset Allocation Index by Year (2021–2021)
Mainz Biomed BV strategic asset allocation index by year from 2021 to 2021. The table below presents the year-by-year Strategic Asset Allocation Index for Mainz Biomed BV from 2021 to 2021, covering 1 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see MYNZ stock market capitalisation.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2021 | 6.8% | $431.59K | $431.59K | $- | $6.36 Million | — |